 Meha (Malmo ¨) and S. Koder
(Vienna) for their contributions to the study.
References
1 Anderson FA Jr, Brownell Wheeler H, Goldberg RJ, Hosmer DW,
Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital i ncidence and case- fatality rates of
deep vein thrombosis and pulmonary embolism. The Worcester DVT
Study. Arch Intern Med 1991; 151: 933–8.
2 Nordstro ¨mM ,L i n d b l a dB ,B e r g q v i s tD ,K j e l l s t r o ¨m T. A prospective
study of the incidence of deep-vein thrombosis within a deﬁned urban
population. JI n t e r nM e d 1992; 232: 155–60.
3 Prandoni P, Lensing AW, Cogo A , Cuppini S, Villalta S, Carta M,
Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-termclinical course of acute deep venous thrombosis. Ann Intern Med 1996;
125: 1–7.
4 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet
1999; 353: 1167–73.
5 Seligsohn U, Zivelin A. Thrombop hilia as a multigenic disorder.
Thromb Haemost 1997; 78: 297–301.
6 Bovill EG, Hasstedt SJ, Leppert MF, Long GL. Hereditary throm-
bophilia as a model for multigenic disease. Thromb Haemost 1999; 82:
662–6.
7 Thaler E, Lechner K. Antithrombin III deﬁciency and thromboem-
bolism. Clin Haematol 1981; 10: 369–90.
8 Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C
deﬁciency and venous thromboembolism. A study of three Dutch
families. NE n g lJM e d 1983; 309: 340–4.
9 Broekmans AW, Bertina RM, Reinalda-Poot J, Engesser L, Muller
HP, Leeuw JA, Michiels JJ, Brommer EJ, Brie ¨tE .H e r e d i t a r yp r o t e i n
S deﬁciency and venous thrombo-embolism. A study in three Dutch
families. Thromb Haemost 1985; 53: 273–7.
10 Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP.
Resistance to activated protein C and factor V Leiden as risk factors
for venous thrombosis. Thromb Haemost 1995; 74: 449–53.
11 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A com-
m o ng e n e t i cv a r i a t i o ni nt h e3 ¢-untranslated region of the
prothrombin gene is associated with elevated plasma pro-
thrombin levels and an incre ase in venous thrombosis. Blood 1996; 88:
3698–703.
12 Lensen RP, Rosendaal FR, Koster T, Allaart CF, de Ronde H,
Vandenbroucke JP, Reitsma PH, Bertina RM. Apparent diﬀerent
thrombotic tendency in patients with factor V Leiden and protein Cdeﬁciency due to selection of patients. Blood 1996; 88: 4205–8.
13 Lensen RP, Bertina RM, de Ronde H, Vandenbroucke JP,
Rosendaal FR. Venous thrombotic risk in family members of unse-
lected individuals with factor V Leiden. Thromb Haemost 2000; 83:
817–21.
14 Vossen CY, Conard J, Fontcuberta J, Makris M, van der Meer FJ,
Pabinger I, Palareti G, Preston FE, Scharrer I, Souto JC, Svensson P,Walker ID, Rosendaal FR. Familial thrombophilia and lifetime risk
of venous thrombosis. J Thromb Haemost 2004; 2: 1526–32.
15 Wissenschaftliche Tabellen Geigy. Teilband Statistik ,V o l .8 .B a s e l ,
1980: 152.
16 Bucciarelli P, Rosendaal FR, Tr i p o d iA ,M a n n u c c iP M ,D eS t e f a n o
V, Palareti G, Finazzi G, Baudo F, Quintavalla R. Risk of venousthromboembolism and clinical manifestations in carriers of anti-
thrombin, protein C, protein S deﬁciency, or activated protein C
resistance: a multicenter c ollaborative family study. Arterioscler
Thromb Vasc Biol 1999; 19: 1026–33.
17 Tirado I, Mateo J, Soria JM, Oliver A, Borrell M, Coll I, Vallve ´C,
Souto JC, Martı ´nez-Sa ´nchez E, Fontcuberta J. Contribution of pro-
thrombin 20210A allele and facto r V Leiden mutation to thrombosis
risk in thrombophilic families with o ther hemostatic deﬁciencies.
Haematologica 2001; 86: 1200–8.
18 Sanson BJ, Simioni P, Tormene D ,M o i aM ,F r i e d e r i c hP W ,H u i s m a n
MV, Prandoni P, Bura A, Rejt }o L, Wells P, Mannucci PM, Girolami
A, Bu ¨ller HR, Prins MH. The incidence of venous thromboembolism
in asymptomatic carriers of a deﬁciency of antithrombin, protein C, or
protein S: a prospective cohort study. Blood 1999; 94: 3702–6.
19 Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F,
Paciaroni K, Leone G, Faioni EM. Diﬀerent risks of thrombosis in
four coagulation defects associat ed with inherited thrombophilia. a
study of 150 families. Blood 1998; 92: 2353–8.
20 De Stefano V, Leone G, Mastrangelo S, Tripodi A, Rodeghiero F,
Castaman G, Barbui T, Finazzi G, Bizzi B, Mannucci PM. Clinical
manifestations and management of i nherited thrombophilia. retro-
spective analysis and follow-up after diagnosis of 238 patients withcongenital deﬁcienc y of antithrombin III, protein C, protein S.
Thromb Haemost 1994; 72: 352–8.
21 van Boven HH, Vandenbroucke JP, Brie ¨t E, Rosendaal FR. Gene–
gene and gene–environment interactions determine risk of thrombosisin families with inherited antithrombin deﬁciency. Blood 1999; 94:
2590–4.
22 Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittmann E,
Lechner K.